Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 5Plasma cell 1Other hematologic neoplasm 1Lymphoid 1

Conditions

Multiple Myeloma 30Hodgkin Disease 17Leukemia, Lymphocytic, Chronic, B-Cell 15Precursor Cell Lymphoblastic Leukemia-Lymphoma 14Myelodysplastic Syndromes 14Lymphoma, Non-Hodgkin 13Leukemia, Myeloid, Acute 13Myeloproliferative Disorders 11Lymphoma, Mantle-Cell 11Primary Myelofibrosis 10Neoplasms, Plasma Cell 10Lymphoma, Large B-Cell, Diffuse 10Leukemia, Myelogenous, Chronic, BCR-ABL Positive 10Waldenstrom Macroglobulinemia 9Lymphoma, Follicular 9Lymphoma 9Leukemia 9Graft vs Host Disease 9Lymphoma, B-Cell, Marginal Zone 8Leukemia, Myelomonocytic, Chronic 8Burkitt Lymphoma 8Myelodysplastic-Myeloproliferative Diseases 7Leukemia, Prolymphocytic 7Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 7Leukemia, Myeloid, Accelerated Phase 7Lymphoma, Large-Cell, Immunoblastic 6Lymphoma, Large-Cell, Anaplastic 6Leukemia, Myeloid, Chronic-Phase 6Blast Crisis 6Lymphoma, T-Cell, Cutaneous 5

Interventions

cc-486 1Sirolimus 1Quality of Life 1Prednisone 1Patient Reported Outcome Measures 1Molecular Diagnostic Techniques 1Injections 1Immunotherapy 1Everolimus 1Drug Therapy 1Biological Therapy 1Azacitidine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Skin Neoplasms × Sirolimus × Plasma cell × Clear all
NCT07426484 2026-02-23

Cosibelimab for CSCC in Patients With Kidney Transplant or Hematologic Malignancy

Dana-Farber Cancer Institute

Phase 4 Not yet recruiting
80 enrolled
DermatologicLymphoidOther hematologic neoplasmPlasma cell

Lymphoma, Waldenstrom Macroglobulinemia, Skin Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡